Beyond their traditional role in haemostasis and thrombosis, platelets are increasingly recognised as immune modulatory cells. Activated platelets and platelet-derived microparticles can bind to leukocytes, which stimulates mutual activation and results in rapid, local release of platelet-derived cytokines. Thereby platelets modulate leukocyte effector functions and contribute to inflammatory and immune responses to injury or infection. Platelets enhance leukocyte extravasation, differentiation and cytokine release. Platelet-neutrophil interactions boost oxidative burst, neutrophil extracellular trap formation and phagocytosis and play an important role in host defence. Platelet interactions with monocytes propagate their differentiation into macrophages, modulate cytokine release and attenuate macrophage functions. Depending on the underlying pathology, platelets can enhance or diminish leukocyte cytokine production, indicating that platelet-leukocyte interactions represent a fine balanced system to restrict excessive inflammation during infection. In atherosclerosis, platelet interaction with neutrophils, monocytes and dendritic cells accelerates key steps of atherogenesis by promoting leukocyte extravasation and foam cell formation. Platelet-leukocyte interactions at sites of atherosclerotic lesions destabilise atherosclerotic plaques and promote plaque rupture. Leukocytes in turn also modulate platelet function and production, which either results in enhanced platelet destruction or increased platelet production. This review aims to summarise the key effects of platelet-leukocyte interactions in inflammation, infection and atherosclerosis.

Keywords:
Platelets, Platelet-leukocyte aggregates, P-selectin, Inflammation, Infection, Cardiovascular disease
1.
Schrottmaier WC, Kral JB, Badrnya S, Assinger A: Aspirin and P2Y12 inhibitors in platelet-mediated activation of neutrophils and monocytes. Thromb Haemost 2015;114:478-489.
2.
McNicol A, Israels SJ: Beyond hemostasis: the role of platelets in inflammation, malignancy and infection. Cardiovasc Hematol Disord Drug Targets 2008;8:99-117.
3.
Heijnen H, van der Sluijs P: Platelet secretory behaviour: as diverse as the granules ... or not? J Thromb Haemost 2015;13:2141-2151.
4.
Veljkovic DK, Cramer EM, Alimardani G, Fichelson S, Masse JM, Hayward CP: Studies of alpha-granule proteins in cultured human megakaryocytes. Thromb Haemost 2003;90:844-852.
5.
Lindemann S, Tolley ND, Dixon DA, McIntyre TM, Prescott SM, Zimmerman GA, Weyrich AS: Activated platelets mediate inflammatory signaling by regulated interleukin 1beta synthesis. J Cell Biol 2001;154:485-490.
6.
Allam O, Samarani S, Marzouk R, Ahmad A: Human platelets produce and constitute the main source of il-18 in the circulation. J Immunol 2012;188 (Meeting Abstract Suppl):44.25.
7.
Mack M, Kleinschmidt A, Bruhl H, Klier C, Nelson PJ, Cihak J, Plachy J, Stangassinger M, Erfle V, Schlondorff D: Transfer of the chemokine receptor ccr5 between cells by membrane-derived microparticles: a mechanism for cellular human immunodeficiency virus 1 infection. Nat Med 2000;6:769-775.
8.
Rozmyslowicz T, Majka M, Kijowski J, Murphy SL, Conover DO, Poncz M, Ratajczak J, Gaulton GN, Ratajczak MZ: Platelet- and megakaryocyte-derived microparticles transfer CXCR4 receptor to CXCR4-null cells and make them susceptible to infection by X4-HIV. Aids 2003;17:33-42.
9.
Fu BH, Fu ZZ, Meng W, Gu T, Sun XD, Zhang Z: Platelet VEGF and serum TGF-beta1 levels predict chemotherapy response in non-small cell lung cancer patients. Tumour Biol 2015;36:6477-6483.
10.
Peterson JE, Zurakowski D, Italiano JE Jr, Michel LV, Connors S, Oenick M, D'Amato RJ, Klement GL, Folkman J: VEGF, PF4 and PDGF are elevated in platelets of colorectal cancer patients. Angiogenesis 2012;15:265-273.
11.
Schror K, Huber K: Platelets, inflammation and anti-inflammatory drugs in ACS and CAD. Thromb Haemost 2015;114:446-448.
12.
Hillgruber C, Steingraber AK, Poppelmann B, Denis CV, Ware J, Vestweber D, Nieswandt B, Schneider SW, Goerge T: Blocking von Willebrand factor for treatment of cutaneous inflammation. J Invest Dermatol 2014;134:77-86.
13.
Slaba I, Wang J, Kolaczkowska E, McDonald B, Lee WY, Kubes P: Imaging the dynamic platelet-neutrophil response in sterile liver injury and repair in mice. Hepatology 2015;62:1593-1605.
14.
Weber C, Springer TA: Neutrophil accumulation on activated, surface-adherent platelets in flow is mediated by interaction of Mac-1 with fibrinogen bound to alphaiibbeta3 and stimulated by platelet-activating factor. J Clin Invest 1997;100:2085-2093.
15.
Diacovo TG, Roth SJ, Buccola JM, Bainton DF, Springer TA: Neutrophil rolling, arrest, and transmigration across activated, surface-adherent platelets via sequential action of P-selectin and the beta 2-integrin CD11b/CD18. Blood 1996;88:146-157.
16.
Kuligowski MP, Kitching AR, Hickey MJ: Leukocyte recruitment to the inflamed glomerulus: a critical role for platelet-derived p-selectin in the absence of rolling. J Immunol 2006;176:6991-6999.
17.
Stone PC, Nash GB: Conditions under which immobilized platelets activate as well as capture flowing neutrophils. Br J Haematol 1999;105:514-522.
18.
Lam FW, Burns AR, Smith CW, Rumbaut RE: Platelets enhance neutrophil transendothelial migration via P-selectin glycoprotein ligand-1. Am J Physiol Heart Circ Physiol 2011;300:H468-475.
19.
Rahman M, Roller J, Zhang S, Syk I, Menger MD, Jeppsson B, Thorlacius H: Metalloproteinases regulate CD40l shedding from platelets and pulmonary recruitment of neutrophils in abdominal sepsis. Inflamm Res 2012;61:571-579.
20.
Sreeramkumar V, Adrover JM, Ballesteros I, Cuartero MI, Rossaint J, Bilbao I, Nacher M, Pitaval C, Radovanovic I, Fukui Y, McEver RP, Filippi MD, Lizasoain I, Ruiz-Cabello J, Zarbock A, Moro MA, Hidalgo A: Neutrophils scan for activated platelets to initiate inflammation. Science 2014;346:1234-1238.
21.
Singh MV, Davidson DC, Jackson JW, Singh VB, Silva J, Ramirez SH, Maggirwar SB: Characterization of platelet-monocyte complexes in HIV-1-infected individuals: possible role in HIV-associated neuroinflammation. J Immunol 2014;192:4674-4684.
22.
Badrnya S, Schrottmaier WC, Kral JB, Yaiw KC, Volf I, Schabbauer G, Soderberg-Naucler C, Assinger A: Platelets mediate oxidized low-density lipoprotein-induced monocyte extravasation and foam cell formation. Arterioscler Thromb Vasc Biol 2014;34:571-580.
23.
Zirlik A, Maier C, Gerdes N, MacFarlane L, Soosairajah J, Bavendiek U, Ahrens I, Ernst S, Bassler N, Missiou A, Patko Z, Aikawa M, Schonbeck U, Bode C, Libby P, Peter K: CD40 ligand mediates inflammation independently of CD40 by interaction with Mac-1. Circulation 2007;115:1571-1580.
24.
Schulz C, von Bruhl ML, Barocke V, Cullen P, Mayer K, Okrojek R, Steinhart A, Ahmad Z, Kremmer E, Nieswandt B, Frampton J, Massberg S, Schmidt R: EMMPRIN (CD147/basigin) mediates platelet-monocyte interactions in vivo and augments monocyte recruitment to the vascular wall. J Thromb Haemost 2011;9:1007-1019.
25.
Armstrong PC, Kirkby NS, Chan MV, Finsterbusch M, Hogg N, Nourshargh S, Warner TD: Novel whole blood assay for phenotyping platelet reactivity in mice identifies ICAM-1 as a mediator of platelet-monocyte interaction. Blood 2015;126:e11-18.
26.
von Hundelshausen P, Koenen RR, Sack M, Mause SF, Adriaens W, Proudfoot AE, Hackeng TM, Weber C: Heterophilic interactions of platelet factor 4 and RANTES promote monocyte arrest on endothelium. Blood 2005;105:924-930.
27.
Wirtz TH, Tillmann S, Strussmann T, Kraemer S, Heemskerk JW, Grottke O, Gawaz M, von Hundelshausen P, Bernhagen J: Platelet-derived MIF: a novel platelet chemokine with distinct recruitment properties. Atherosclerosis 2015;239:1-10.
28.
Chatterjee M, von Ungern-Sternberg SN, Seizer P, Schlegel F, Buttcher M, Sindhu NA, Muller S, Mack A, Gawaz M: Platelet-derived CXCL12 regulates monocyte function, survival, differentiation into macrophages and foam cells through differential involvement of CXCR4-CXCR7. Cell Death Dis 2015;6:e1989.
29.
Strussmann T, Tillmann S, Wirtz T, Bucala R, von Hundelshausen P, Bernhagen J: Platelets are a previously unrecognised source of MIF. Thromb Haemost 2013;110:1004-1013.
30.
Duerschmied D, Suidan GL, Demers M, Herr N, Carbo C, Brill A, Cifuni SM, Mauler M, Cicko S, Bader M, Idzko M, Bode C, Wagner DD: Platelet serotonin promotes the recruitment of neutrophils to sites of acute inflammation in mice. Blood 2013;121:1008-1015.
31.
Assinger A, Laky M, Schabbauer G, Hirschl AM, Buchberger E, Binder BR, Volf I: Efficient phagocytosis of periodontopathogens by neutrophils requires plasma factors, platelets and TLR2. J Thromb Haemost 2011;9:799-809.
32.
Peters MJ, Dixon G, Kotowicz KT, Hatch DJ, Heyderman RS, Klein NJ: Circulating platelet-neutrophil complexes represent a subpopulation of activated neutrophils primed for adhesion, phagocytosis and intracellular killing. Br J Haematol 1999;106:391-399.
33.
Hurley SM, Kahn F, Nordenfelt P, Morgelin M, Sorensen OE, Shannon O: Platelet-dependent neutrophil function is dysregulated by m protein from Streptococcus pyogenes. Infect Immun 2015;83:3515-3525.
34.
Jy W, Mao WW, Horstman L, Tao J, Ahn YS: Platelet microparticles bind, activate and aggregate neutrophils in vitro. Blood Cells Mol Dis 1995;21:217-231; discussion 231a.
35.
Caudrillier A, Kessenbrock K, Gilliss BM, Nguyen JX, Marques MB, Monestier M, Toy P, Werb Z, Looney MR: Platelets induce neutrophil extracellular traps in transfusion-related acute lung injury. J Clin Invest 2012;122:2661-2671.
36.
Etulain J, Martinod K, Wong SL, Cifuni SM, Schattner M, Wagner DD: P-selectin promotes neutrophil extracellular trap formation in mice. Blood 2015;126:242-246.
37.
von Bruhl ML, Stark K, Steinhart A, Chandraratne S, Konrad I, Lorenz M, Khandoga A, Tirniceriu A, Coletti R, Kollnberger M, Byrne RA, Laitinen I, Walch A, Brill A, Pfeiler S, Manukyan D, Braun S, Lange P, Riegger J, Ware J, Eckart A, Haidari S, Rudelius M, Schulz C, Echtler K, Brinkmann V, Schwaiger M, Preissner KT, Wagner DD, Mackman N, Engelmann B, Massberg S: Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo. J Exp Med 2012;209:819-835.
38.
McDonald B, Kubes P: Neutrophils and intravascular immunity in the liver during infection and sterile inflammation. Toxicol Pathol 2012;40:157-165.
39.
Kraemer BF, Campbell RA, Schwertz H, Cody MJ, Franks Z, Tolley ND, Kahr WH, Lindemann S, Seizer P, Yost CC, Zimmerman GA, Weyrich AS: Novel anti-bacterial activities of beta-defensin 1 in human platelets: suppression of pathogen growth and signaling of neutrophil extracellular trap formation. PLoS Pathog 2011;7:e1002355.
40.
Carestia A, Kaufman T, Rivadeneyra L, Landoni VI, Pozner RG, Negrotto S, D'Atri LP, Gomez RM, Schattner M: Mediators and molecular pathways involved in the regulation of neutrophil extracellular trap formation mediated by activated platelets. J Leukoc Biol 2016;99:153-162.
41.
Maugeri N, Campana L, Gavina M, Covino C, De Metrio M, Panciroli C, Maiuri L, Maseri A, D'Angelo A, Bianchi ME, Rovere-Querini P, Manfredi AA: Activated platelets present high mobility group box 1 to neutrophils, inducing autophagy and promoting the extrusion of neutrophil extracellular traps. J Thromb Haemost 2014;12:2074-2088.
42.
Powers ME, Becker RE, Sailer A, Turner JR, Bubeck Wardenburg J: Synergistic action of Staphylococcus aureus alpha-toxin on platelets and myeloid lineage cells contributes to lethal sepsis. Cell Host Microbe 2015;17:775-787.
43.
Yu C, Zhang S, Wang Y, Zhang S, Luo L, Thorlacius H: Platelet-derived CCL5 regulates CXC chemokine formation and neutrophil recruitment in acute experimental colitis. J Cell Physiol 2016;231:370-376.
44.
Gros A, Syvannarath V, Lamrani L, Ollivier V, Loyau S, Goerge T, Nieswandt B, Jandrot-Perrus M, Ho-Tin-Noe B: Single platelets seal neutrophil-induced vascular breaches via GPVI during immune-complex-mediated inflammation in mice. Blood 2015;126:1017-1026.
45.
Parimon T, Li Z, Bolz DD, McIndoo ER, Bayer CR, Stevens DL, Bryant AE: Staphylococcus aureus alpha-hemolysin promotes platelet-neutrophil aggregate formation. J Infect Dis 2013;208:761-770.
46.
Ortiz-Munoz G, Mallavia B, Bins A, Headley M, Krummel MF, Looney MR: Aspirin-triggered 15-epi-lipoxin A4 regulates neutrophil-platelet aggregation and attenuates acute lung injury in mice. Blood 2014;124:2625-2634.
47.
Hottz ED, Medeiros-de-Moraes IM, Vieira-de-Abreu A, de Assis EF, Vals-de-Souza R, Castro-Faria-Neto HC, Weyrich AS, Zimmerman GA, Bozza FA, Bozza PT: Platelet activation and apoptosis modulate monocyte inflammatory responses in dengue. J Immunol 2014;193:1864-1872.
48.
Assinger A, Kral JB, Yaiw KC, Schrottmaier WC, Kurzejamska E, Wang Y, Mohammad AA, Religa P, Rahbar A, Schabbauer G, Butler LM, Soderberg-Naucler C: Human cytomegalovirus-platelet interaction triggers toll-like receptor 2-dependent proinflammatory and proangiogenic responses. Arterioscler Thromb Vasc Biol 2014;34:801-809.
49.
Vanichakarn P, Blair P, Wu C, Freedman JE, Chakrabarti S: Neutrophil CD40 enhances platelet-mediated inflammation. Thromb Res 2008;122:346-358.
50.
Maugeri N, Rovere-Querini P, Baldini M, Baldissera E, Sabbadini MG, Bianchi ME, Manfredi AA: Oxidative stress elicits platelet/leukocyte inflammatory interactions via HMGB1: a candidate for microvessel injury in sytemic sclerosis. Antioxid Redox Signal 2014;20:1060-1074.
51.
Pervushina O, Scheuerer B, Reiling N, Behnke L, Schroder JM, Kasper B, Brandt E, Bulfone-Paus S, Petersen F: Platelet factor 4/CXCL4 induces phagocytosis and the generation of reactive oxygen metabolites in mononuclear phagocytes independently of GI protein activation or intracellular calcium transients. J Immunol 2004;173:2060-2067.
52.
Kasper B, Brandt E, Brandau S, Petersen F: Platelet factor 4 (CXC chemokine ligand 4) differentially regulates respiratory burst, survival, and cytokine expression of human monocytes by using distinct signaling pathways. J Immunol 2007;179:2584-2591.
53.
Lecut C, Faccinetto C, Delierneux C, van Oerle R, Spronk HM, Evans RJ, El Benna J, Bours V, Oury C: ATP-gated P2X1 ion channels protect against endotoxemia by dampening neutrophil activation. J Thromb Haemost 2012;10:453-465.
54.
Yang J, Zhang L, Yu C, Yang XF, Wang H: Monocyte and macrophage differentiation: circulation inflammatory monocyte as biomarker for inflammatory diseases. Biomark Res 2014;2:1.
55.
Idzkowska E, Eljaszewicz A, Miklasz P, Musial WJ, Tycinska AM, Moniuszko M: The role of different monocyte subsets in the pathogenesis of atherosclerosis and acute coronary syndromes. Scand J Immunol 2015;82:163-173.
56.
Weyrich AS, Elstad MR, McEver RP, McIntyre TM, Moore KL, Morrissey JH, Prescott SM, Zimmerman GA: Activated platelets signal chemokine synthesis by human monocytes. J Clin Invest 1996;97:1525-1534.
57.
Christersson C, Johnell M, Siegbahn A: Tissue factor and IL8 production by P-selectin-dependent platelet-monocyte aggregates in whole blood involves phosphorylation of Lyn and is inhibited by IL10. J Thromb Haemost 2008;6:986-994.
58.
Phillips JH, Chang CW, Lanier LL: Platelet-induced expression of Fc gamma RIII (CD16) on human monocytes. Eur J Immunol 1991;21:895-899.
59.
Eligini S, Barbieri SS, Arenaz I, Tremoli E, Colli S: Paracrine up-regulation of monocyte cyclooxygenase-2 by platelets: role of transforming growth factor-beta1. Cardiovasc Res 2007;74:270-278.
60.
Suzuki J, Hamada E, Shodai T, Kamoshida G, Kudo S, Itoh S, Koike J, Nagata K, Irimura T, Tsuji T: Cytokine secretion from human monocytes potentiated by P-selectin-mediated cell adhesion. Int Arch Allergy Immunol 2013;160:152-160.
61.
Otterdal K, Smith C, Oie E, Pedersen TM, Yndestad A, Stang E, Endresen K, Solum NO, Aukrust P, Damas JK: Platelet-derived light induces inflammatory responses in endothelial cells and monocytes. Blood 2006;108:928-935.
62.
Stephen J, Emerson B, Fox KA, Dransfield I: The uncoupling of monocyte-platelet interactions from the induction of proinflammatory signaling in monocytes. J Immunol 2013;191:5677-5683.
63.
Vasina EM, Cauwenberghs S, Feijge MA, Heemskerk JW, Weber C, Koenen RR: Microparticles from apoptotic platelets promote resident macrophage differentiation. Cell Death Dis 2011;2:e211.
64.
Rong MY, Wang CH, Wu ZB, Zeng W, Zheng ZH, Han Q, Jia JF, Li XY, Zhu P: Platelets induce a proinflammatory phenotype in monocytes via the CD147 pathway in rheumatoid arthritis. Arthritis Res Ther 2014;16:478.
65.
Tunjungputri RN, van der Ven AJ, Riksen N, Rongen G, Tacke S, van den Berg TN, Fijnheer R, Gomes ME, Dinarello CA, van de Veerdonk FL, Gasem MH, Netea MG, Joosten LA, de Groot PG, de Mast Q: Differential effects of platelets and platelet inhibition by ticagrelor on TLR2- and TLR4-mediated inflammatory responses. Thromb Haemost 2015;113:1035-1045.
66.
Wu BQ, Zhi MJ, Liu H, Huang J, Zhou YQ, Zhang TT: Inhibitory effects of lipoteichoic acid from Staphylococcus aureus on platelet function and platelet-monocyte aggregation. Inflamm Res 2011;60:775-782.
67.
Thomas MR, Outteridge SN, Ajjan RA, Phoenix F, Sangha GK, Faulkner RE, Ecob R, Judge HM, Khan H, West LE, Dockrell DH, Sabroe I, Storey RF: Platelet P2Y12 inhibitors reduce systemic inflammation and its prothrombotic effects in an experimental human model. Arterioscler Thromb Vasc Biol 2015;35:2562-2570.
68.
Totani L, Dell'Elba G, Martelli N, Di Santo A, Piccoli A, Amore C, Evangelista V: Prasugrel inhibits platelet-leukocyte interaction and reduces inflammatory markers in a model of endotoxic shock in the mouse. Thromb Haemost 2012;107:1130-1140.
69.
Hwaiz R, Rahman M, Syk I, Zhang E, Thorlacius H: Rac1-dependent secretion of platelet-derived CCL5 regulates neutrophil recruitment via activation of alveolar macrophages in septic lung injury. J Leukoc Biol 2015; doi: 10.1189/jlb.4A1214-603R.
70.
Hwaiz R, Rahman M, Zhang E, Thorlacius H: Platelet secretion of CXCL4 is Rac1-dependent and regulates neutrophil infiltration and tissue damage in septic lung damage. Br J Pharmacol 2015;172:5347-5359.
71.
Duffau P, Seneschal J, Nicco C, Richez C, Lazaro E, Douchet I, Bordes C, Viallard JF, Goulvestre C, Pellegrin JL, Weil B, Moreau JF, Batteux F, Blanco P: Platelet CD154 potentiates interferon-alpha secretion by plasmacytoid dendritic cells in systemic lupus erythematosus. Sci Translat Med 2010;2:47ra63.
72.
Clark SR, Ma AC, Tavener SA, McDonald B, Goodarzi Z, Kelly MM, Patel KD, Chakrabarti S, McAvoy E, Sinclair GD, Keys EM, Allen-Vercoe E, Devinney R, Doig CJ, Green FH, Kubes P: Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood. Nat Med 2007;13:463-469.
73.
Schwartzkopff F, Petersen F, Grimm TA, Brandt E: Cxc chemokine ligand 4 (CXCL4) down-regulates CC chemokine receptor expression on human monocytes. Innate Immun 2012;18:124-139.
74.
Mack M, Pfirstinger J, Weber C, Weber KS, Nelson PJ, Rupp T, Maletz K, Bruhl H, Schlondorff D: Chondroitin sulfate a released from platelets blocks RANTES presentation on cell surfaces and RANTES-dependent firm adhesion of leukocytes. Eur J Immunol 2002;32:1012-1020.
75.
Gudbrandsdottir S, Hasselbalch HC, Nielsen CH: Activated platelets enhance IL-10 secretion and reduce TNF-alpha secretion by monocytes. J Immunol 2013;191:4059-4067.
76.
Ando Y, Oku T, Tsuji T: Platelets attenuate production of cytokines and nitric oxide by macrophages in response to bacterial endotoxin. Platelets 2015:1-7.
77.
Inui M, Tazawa K, Kishi Y, Takai T: Platelets convert peripheral blood circulating monocytes to regulatory cells via immunoglobulin g and activating-type FCγ receptors. BMC Immunol 2015;16:20.
78.
Corken A, Russell S, Dent J, Post SR, Ware J: Platelet glycoprotein Ib-IX as a regulator of systemic inflammation. Arterioscler Thromb Vasc Biol 2014;34:996-1001.
79.
Brancaleone V, Gobbetti T, Cenac N, le Faouder P, Colom B, Flower RJ, Vergnolle N, Nourshargh S, Perretti M: A vasculo-protective circuit centered on lipoxin a4 and aspirin-triggered 15-epi-lipoxin a4 operative in murine microcirculation. Blood 2013;122:608-617.
80.
Brunetti M, Martelli N, Manarini S, Mascetra N, Musiani P, Cerletti C, Aiello FB, Evangelista V: Polymorphonuclear leukocyte apoptosis is inhibited by platelet-released mediators, role of TGFbeta-1. Thromb Haemost 2000;84:478-483.
81.
Ariel A, Fredman G, Sun YP, Kantarci A, Van Dyke TE, Luster AD, Serhan CN: Apoptotic neutrophils and T cells sequester chemokines during immune response resolution through modulation of CCR5 expression. Nat Immunol 2006;7:1209-1216.
82.
Hilf N, Singh-Jasuja H, Schwarzmaier P, Gouttefangeas C, Rammensee HG, Schild H: Human platelets express heat shock protein receptors and regulate dendritic cell maturation. Blood 2002;99:3676-3682.
83.
Huo Y, Schober A, Forlow SB, Smith DF, Hyman MC, Jung S, Littman DR, Weber C, Ley K: Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein e. Nat Med 2003;9:61-67.
84.
Karshovska E, Zhao Z, Blanchet X, Schmitt MM, Bidzhekov K, Soehnlein O, von Hundelshausen P, Mattheij NJ, Cosemans JM, Megens RT, Koeppel TA, Schober A, Hackeng TM, Weber C, Koenen RR: Hyperreactivity of junctional adhesion molecule A-deficient platelets accelerates atherosclerosis in hyperlipidemic mice. Circ Res 2015;116:587-599.
85.
Jickling GC, Liu D, Ander BP, Stamova B, Zhan X, Sharp FR: Targeting neutrophils in ischemic stroke: translational insights from experimental studies. J Cereb Blood Flow Metab 2015;35:888-901.
86.
von Hundelshausen P, Schmitt MM: Platelets and their chemokines in atherosclerosis - clinical applications. Front Physiol 2014;5:294.
87.
Badrnya S, Butler LM, Soderberg-Naucler C, Volf I, Assinger A: Platelets directly enhance neutrophil transmigration in response to oxidised low-density lipoprotein. Thromb Haemost 2012;108:719-729.
88.
Langer HF, Daub K, Braun G, Schonberger T, May AE, Schaller M, Stein GM, Stellos K, Bueltmann A, Siegel-Axel D, Wendel HP, Aebert H, Roecken M, Seizer P, Santoso S, Wesselborg S, Brossart P, Gawaz M: Platelets recruit human dendritic cells via MAC-1/JAM-C interaction and modulate dendritic cell function in vitro. Arterioscler Thromb Vasc Biol 2007;27:1463-1470.
89.
Lievens D, Zernecke A, Seijkens T, Soehnlein O, Beckers L, Munnix IC, Wijnands E, Goossens P, van Kruchten R, Thevissen L, Boon L, Flavell RA, Noelle RJ, Gerdes N, Biessen EA, Daemen MJ, Heemskerk JW, Weber C, Lutgens E: Platelet CD40L mediates thrombotic and inflammatory processes in atherosclerosis. Blood 2010;116:4317-4327.
90.
Scheuerer B, Ernst M, Durrbaum-Landmann I, Fleischer J, Grage-Griebenow E, Brandt E, Flad HD, Petersen F: The CXC-chemokine platelet factor 4 promotes monocyte survival and induces monocyte differentiation into macrophages. Blood 2000;95:1158-1166.
91.
Gleissner CA: Macrophage phenotype modulation by cxcl4 in atherosclerosis. Front Physiol 2012;3:1.
92.
Mendelsohn ME, Loscalzo J: Role of platelets in cholesteryl ester formation by U-937 cells. J Clin Invest 1988;81:62-68.
93.
Daub K, Langer H, Seizer P, Stellos K, May AE, Goyal P, Bigalke B, Schonberger T, Geisler T, Siegel-Axel D, Oostendorp RA, Lindemann S, Gawaz M: Platelets induce differentiation of human CD34+ progenitor cells into foam cells and endothelial cells. FASEBJ 2006;20:2559-2561.
94.
De Meyer GR, De Cleen DM, Cooper S, Knaapen MW, Jans DM, Martinet W, Herman AG, Bult H, Kockx MM: Platelet phagocytosis and processing of beta-amyloid precursor protein as a mechanism of macrophage activation in atherosclerosis. Circ Res 2002;90:1197-1204.
95.
Nassar T, Sachais BS, Akkawi S, Kowalska MA, Bdeir K, Leitersdorf E, Hiss E, Ziporen L, Aviram M, Cines D, Poncz M, Higazi AA: Platelet factor 4 enhances the binding of oxidized low-density lipoprotein to vascular wall cells. J Biol Chem 2003;278:6187-6193.
96.
Fuhrman B, Brook GJ, Aviram M: Proteins derived from platelet alpha granules modulate the uptake of oxidized low density lipoprotein by macrophages. Biochim Biophys Acta 1992;1127:15-21.
97.
Sachais BS, Turrentine T, Dawicki McKenna JM, Rux AH, Rader D, Kowalska MA: Elimination of platelet factor 4 (PF4) from platelets reduces atherosclerosis in C57Bl/6 and apoE-/- mice. Thromb Haemost 2007;98:1108-1113.
98.
Ikuta T, Naruko T, Ikura Y, Ohsawa M, Fukushima H, Shirai N, Itoh A, Haze K, Ehara S, Sasaki Y, Shibata T, Suehiro S, Ueda M: Immunolocalization of platelet glycoprotein IIb/IIIa and P-selectin, and neutrophil-platelet interaction in human coronary unstable plaques. Int J Mol Med 2005;15:573-577.
99.
Haseruck N, Erl W, Pandey D, Tigyi G, Ohlmann P, Ravanat C, Gachet C, Siess W: The plaque lipid lysophosphatidic acid stimulates platelet activation and platelet-monocyte aggregate formation in whole blood: Involvement of P2Y1 and P2Y12 receptors. Blood 2004;103:2585-2592.
100.
Schmidt R, Bultmann A, Fischel S, Gillitzer A, Cullen P, Walch A, Jost P, Ungerer M, Tolley ND, Lindemann S, Gawaz M, Schomig A, May AE: Extracellular matrix metalloproteinase inducer (CD147) is a novel receptor on platelets, activates platelets, and augments nuclear factor kappaB-dependent inflammation in monocytes. Circ Res 2008;102:302-309.
101.
Galt SW, Lindemann S, Medd D, Allen LL, Kraiss LW, Harris ES, Prescott SM, McIntyre TM, Weyrich AS, Zimmerman GA: Differential regulation of matrix metalloproteinase-9 by monocytes adherent to collagen and platelets. Circ Res 2001;89:509-516.
102.
Niessner A, Weyand CM: Dendritic cells in atherosclerotic disease. Clin Immunol 2010;134:25-32.
103.
Manfredi AA, Rovere-Querini P, Maugeri N: Dangerous connections: neutrophils and the phagocytic clearance of activated platelets. Curr Opin Hematol 2010;17:3-8.
104.
Maitre B, Mangin PH, Eckly A, Heim V, Cazenave JP, Lanza F, Hanau D, Gachet C: Immature myeloid dendritic cells capture and remove activated platelets from preformed aggregates. J Thromb Haemost 2010;8:2262-2272.
105.
Trinh BQ, Barengo N, Kim SB, Lee JS, Zweidler-McKay PA, Naora H: The homeobox gene DLX4 regulates erythro-megakaryocytic differentiation by stimulating IL-1beta and NF-κB signaling. J Cell Sci 2015;128:3055-3067.
106.
Wickenhauser C, Lorenzen J, Thiele J, Hillienhof A, Jungheim K, Schmitz B, Hansmann ML, Fischer R: Secretion of cytokines (interleukins-1 alpha, -3, and -6 and granulocyte-macrophage colony-stimulating factor) by normal human bone marrow megakaryocytes. Blood 1995;85:685-691.
107.
Jiang S, Levine JD, Fu Y, Deng B, London R, Groopman JE, Avraham H: Cytokine production by primary bone marrow megakaryocytes. Blood 1994;84:4151-4156.
108.
Zheng C, Yang R, Han Z, Zhou B, Liang L, Lu M: TPO-independent megakaryocytopoiesis. Crit Rev Oncol Hematol 2008;65:212-222.
109.
Angchaisuksiri P, Grigus SR, Carlson PL, Krystal GW, Dessypris EN: Secretion of a unique peptide from interleukin-2-stimulated natural killer cells that induces endomitosis in immature human megakaryocytes. Blood 2002;99:130-136.
110.
Machlus KR, Thon JN, Italiano JE Jr: Interpreting the developmental dance of the megakaryocyte: a review of the cellular and molecular processes mediating platelet formation. Br J Haematol 2014;165:227-236.
111.
Ricciardi S, Miluzio A, Brina D, Clarke K, Bonomo M, Aiolfi R, Guidotti LG, Falciani F, Biffo S: Eukaryotic translation initiation factor 6 is a novel regulator of reactive oxygen species-dependent megakaryocyte maturation. J Thromb Haemost 2015;13:2108-2118.
112.
Wu D, Xie J, Wang X, Zou B, Yu Y, Jing T, Zhang S, Zhang Q: Micro-concentration lipopolysaccharide as a novel stimulator of megakaryocytopoiesis that synergizes with IL-6 for platelet production. Sci Rep 2015;5:13748.
113.
Nishimura S, Nagasaki M, Kunishima S, Sawaguchi A, Sakata A, Sakaguchi H, Ohmori T, Manabe I, Italiano JE, Jr., Ryu T, Takayama N, Komuro I, Kadowaki T, Eto K, Nagai R: IL-1alpha induces thrombopoiesis through megakaryocyte rupture in response to acute platelet needs. J Cell Biol 2015;209:453-466.
114.
Kohler A, De Filippo K, Hasenberg M, van den Brandt C, Nye E, Hosking MP, Lane TE, Mann L, Ransohoff RM, Hauser AE, Winter O, Schraven B, Geiger H, Hogg N, Gunzer M: G-CSF-mediated thrombopoietin release triggers neutrophil motility and mobilization from bone marrow via induction of CXCR2 ligands. Blood 2011;117:4349-4357.
115.
Frisch J, Ganser A, Hoelzer D, Brugger W, Kanz L, Mertelsmann R, Schulz G: Interleukin-3 and granulocyte-macrophage colony-stimulating factor in combination: Clinical implication. Med Pediatr Oncol Suppl 1992;2:34-37.
116.
van Gameren MM, Willemse PH, Mulder NH, Limburg PC, Groen HJ, Vellenga E, de Vries EG: Effects of recombinant human interleukin-6 in cancer patients: a phase I-II study. Blood 1994;84:1434-1441.
© 2016 S. Karger GmbH, Freiburg
2016
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.